Chivukula, Pad

Systemic delivery of factor IX messenger RNA for protein replacement therapy

Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences

Hemophilia Treatment and ResearchRNA Interference and Gene Delivery

Cited by 301

A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice

de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 191

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine

Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2022) · npj Vaccines

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 61

Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions

Milbank, E., Díaz-Trelles, R., Dragano, N., Latorre, J., Mukthavaram, R., Mayneris-Perxachs, J., Ortega, F., Federici, M., Burcelin, R., Karmali, P. P., et al. (2023) · Pharmacological Research

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 26

A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults

Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2021) · medRxiv

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 19